A study funded by Telethon and published in Molecular Therapy proposes the use of invisible nanoparticles in the fight against dystrophy. The work aims to convert the most severe form of muscular dystrophy, the Duchenne (DMD), in the slightest, the Becker dystrophy (DMB).
Focus